In today’s fast-moving AI and digital health landscape, innovation alone is no longer enough. As regulatory expectations rise, payors grow more selective, and investors demand clearer proof of impact, the companies that succeed will be those that turn evidence into a competitive asset — not a compliance afterthought. This talk makes the case that robust, real-world, and multi-dimensional evidence is the next differentiator for digital health and AI companies. Drawing on Prova Health’s work, Gianluca Fontana explores how forward-thinking innovators can raise the bar — and reaping the benefits. This session will challenge founders, funders, and health system leaders to rethink how we build trust in digital health.